Halloween and myocardial infarction: A case-crossover study

2021 ◽  
Author(s):  
Nathalie Auger ◽  
Marianne Bilodeau-Bertrand ◽  
Brian J. Potter
Keyword(s):  
Myocardial Infarction ◽  
Crossover Study ◽  
Case Crossover

Short-term exposure to desert dust and the risk of acute myocardial infarction in Japan: a time-stratified case-crossover study

2020 ◽  
Vol 35 (5) ◽  
pp. 455-464 ◽  
Author(s):  
Masanobu Ishii ◽  
◽  
Tomotsugu Seki ◽  
Koichi Kaikita ◽  
Kenji Sakamoto ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Crossover Study ◽  
Short Term ◽  
Desert Dust ◽  
Case Crossover ◽  
Short Term Exposure

scholarly journals Acute triggers of myocardial infarction: A case-crossover study

2017 ◽  
Vol 69 (4) ◽  
pp. 223-228 ◽  
Author(s):  
Maryam Ghiasmand ◽  
Mohammad Taghi Moghadamnia ◽  
Majid Pourshaikhian ◽  
Ehsan Kazemnejad Lili
Keyword(s):  
Myocardial Infarction ◽  
Crossover Study ◽  
Case Crossover

scholarly journals Decongestant use and the risk of myocardial infarction and stroke: a case-crossover study

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Lamiae Grimaldi-Bensouda ◽  
Bernard Begaud ◽  
Jacques Benichou ◽  
Clementine Nordon ◽  
Olivia Dialla ◽  
...  
Keyword(s):  
Risk Factors ◽  
Myocardial Infarction ◽  
At Risk ◽  
Crossover Study ◽  
Time Window ◽  
Secondary Analysis ◽  
Case Crossover ◽  
Increased Risk ◽  
Disease Registries ◽  
Time Invariant

AbstractPharmacovigilance reports of cerebral and cardiovascular events in those who use decongestants have triggered alerts related to their use. We aimed to assess the risk of stroke and myocardial infarction (MI) associated with the use of decongestants. We conducted a nested case-crossover study of patients with incident stroke and MI identified in France between 2013 and 2016 in two systematic disease registries. Decongestant use in the three weeks preceding the event was assessed using a structured telephone interview. Conditional logistic multivariable models were used to estimate the odds of incident MI and stroke, also accounting for transient risk factors and comparing week 1 (index at-risk time window, immediately preceding the event) to week 3 (reference). Time-invariant risk factors were controlled by design. In total, 1394 patients with MI and 1403 patients with stroke, mainly 70 years old or younger, were interviewed, including 3.2% who used decongestants during the three weeks prior to the event (1.0% definite exposure in the index at-risk time window, 1.1% in the referent time window; adjusted odds ratio (aOR), 0.78; 95%CI, 0.43–1.42). Secondary analysis yielded similar results for individual events (MI/stroke). We observed no increased risk of MI or stroke for patients 70 years of age and younger without previous MI or stroke who used decongestants.

Sign in / Sign up

Export Citation Format

Share Document